Medartis Holding AG

Swiss Stock Exchange MED.SW

Medartis Holding AG Gross Profit Margin for the year ending December 31, 2023: 79.04%

Medartis Holding AG Gross Profit Margin is 79.04% for the year ending December 31, 2023, a 6.73% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Medartis Holding AG Gross Profit Margin for the year ending December 31, 2022 was 74.05%, a -2.61% change year over year.
Medartis Holding AG Gross Profit Margin for the year ending December 31, 2021 was 76.04%, a 3.38% change year over year.
Medartis Holding AG Gross Profit Margin for the year ending December 31, 2020 was 73.55%, a -5.50% change year over year.
Medartis Holding AG Gross Profit Margin for the year ending December 31, 2019 was 77.84%, a -6.51% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Swiss Stock Exchange: MED.SW

Medartis Holding AG

CEO	Mr. Matthias Schupp
IPO Date	March 23, 2018
Location	Switzerland
Headquarters	Hochbergerstrasse 60E
Employees	860
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.

Key trends

Past 5 years